A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
about
Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides.Enrichment and stratification for predementia Alzheimer disease clinical trials.Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementiaCerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.
P2860
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@ast
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@en
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@nl
type
label
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@ast
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@en
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@nl
prefLabel
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@ast
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@en
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@nl
P2093
P2860
P50
P921
P356
P1476
A window into the heterogeneity of human cerebrospinal fluid Aβ peptides
@en
P2093
Elena Stoppani
Luigi F Agnati
Valentina Albertini
P2860
P304
P356
10.1155/2011/697036
P407
P577
2011-08-23T00:00:00Z